Sacral Neuromodulation and OnabotulinumtoxinA for Refractory Urge Urinary Incontinence Offer Similar Success During 2-Year Follow-up

被引：1
|
作者：
Blok, Bertil F. M. [1 ]
机构：
[1] Erasmus MC, Dept Urol, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands
来源：
EUROPEAN UROLOGY | 2018年 / 74卷 / 01期
关键词：
PLACEBO-CONTROLLED TRIAL; OVERACTIVE BLADDER;
D O I：
10.1016/j.eururo.2018.03.016
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：74 / 75
页数：2
相关论文
共 50 条
  • [21] Sacral neuromodulation for the treatment of fecal incontinence and urinary incontinence in female patients: long-term follow-up
    Galal El-Gazzaz
    Massarat Zutshi
    Levilester Salcedo
    Jeff Hammel
    Raymond Rackley
    Tracy Hull
    International Journal of Colorectal Disease, 2009, 24 : 1377 - 1381
  • [22] Re: OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial
    Cornu, Jean-Nicolas
    EUROPEAN UROLOGY, 2017, 71 (06) : 988 - 989
  • [23] Sacral Neuromodulation as Treatment for Refractory Idiopathic Urge Urinary Incontinence: 5-Year Results of a Longitudinal Study in 60 Women
    Groen, Jan
    Blok, Bertil F. M.
    Bosch, J. L. H. Ruud
    JOURNAL OF UROLOGY, 2011, 186 (03): : 954 - 959
  • [24] Seminal papers in urology: two-year outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for refractory urgency urinary incontinence: a Randomized Trial
    Abd Wahab, Haidar Hadri bin
    O'Callaghan, Michael
    BMC UROLOGY, 2024, 24 (01)
  • [25] Seminal papers in urology: two-year outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for refractory urgency urinary incontinence: a Randomized Trial
    Haidar Hadri bin Abd Wahab
    Michael O’Callaghan
    BMC Urology, 24
  • [26] Editorial Comment: Sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: impact on fecal incontinence symptoms and sexual function
    Riccetto, Cassio L. Z.
    INTERNATIONAL BRAZ J UROL, 2020, 46 (04): : 671 - 672
  • [27] Characteristics Associated With Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence
    Richter, Holly E.
    Amundsen, C. L.
    Erickson, S. W.
    Jelovsek, J. E.
    Komesu, Y.
    Chermansky, C.
    Harvie, H. S.
    Albo, M.
    Myers, D.
    Gregory, W. T.
    Wallace, D.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2017, 72 (12) : 709 - 711
  • [28] Re: OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial Comment
    Wein, Alan J.
    JOURNAL OF UROLOGY, 2017, 197 (06): : 1524 - +
  • [29] Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence
    Richter, Holly E.
    Amundsen, C. L.
    Erickson, S. W.
    Jelovsek, J. E.
    Komesu, Y.
    Chermansky, C.
    Harvie, H. S.
    Albo, M.
    Myers, D.
    Gregory, W. T.
    Wallace, D.
    JOURNAL OF UROLOGY, 2017, 198 (04): : 890 - 896
  • [30] Urinary Biomarkers in Women with Refractory Urgency Urinary Incontinence Randomized to Sacral Neuromodulation versus OnabotulinumtoxinA Compared to Controls EDITORIAL COMMENT
    Kuo, Hann-Chorng
    JOURNAL OF UROLOGY, 2017, 197 (06): : 1494 - 1495
12345